Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	65.71	111	134.34	129.32	157.53	92.57
Cash & Short-Term Investments	65.71	111	134.34	129.32	157.53	92.57
Cash Growth	-46.50%	-17.38%	3.89%	-17.91%	70.17%	417.27%
Accounts Receivable	-	-	0.4	4.1	-	-
Other Receivables	-	-	0.95	2.83	-	-
Receivables	-	-	1.35	6.93	-	-
Prepaid Expenses	2.46	2.07	2.47	3.96	3.44	0.34
Restricted Cash	-	-	0.21	-	0.1	-
Total Current Assets	68.17	113.07	138.37	140.2	161.07	92.91
Property, Plant & Equipment	10.51	12.32	14.85	17.45	16.33	3.12
Long-Term Deferred Charges	-	-	-	-	-	0.16
Other Long-Term Assets	0.94	1.54	21.62	2.59	1.86	0.21
Total Assets	79.63	126.93	174.83	160.25	179.25	96.4
Accounts Payable	1.08	3.04	1.34	1.22	2.04	1.02
Accrued Expenses	9.02	10.23	8.41	13.41	8.6	3.49
Current Portion of Long-Term Debt	6	-	6.67	-	-	-
Current Portion of Leases	1.5	1.56	1.61	2.08	1.07	0.68
Current Unearned Revenue	-	-	0.91	6.53	-	-
Other Current Liabilities	-	0.36	0.45	0.74	0.16	0.09
Total Current Liabilities	17.6	15.18	19.38	23.99	11.87	5.28
Long-Term Debt	21.66	26.1	32.66	-	-	-
Long-Term Leases	8.14	9.44	10.99	12.6	14.59	1.86
Long-Term Unearned Revenue	-	-	0.43	1.13	-	-
Other Long-Term Liabilities	2.61	2.83	-	0.19	-	0.03
Total Liabilities	50.01	53.54	63.46	37.91	26.46	7.18
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	496.64	487.97	455.44	429.04	405.68	-
Retained Earnings	-467.03	-414.59	-344.07	-306.71	-252.9	-51.87
Total Common Equity	29.61	73.39	111.37	122.34	152.79	-51.86
Shareholders' Equity	29.61	73.39	111.37	122.34	152.79	89.22
Total Liabilities & Equity	79.63	126.93	174.83	160.25	179.25	96.4
Total Debt	37.3	37.09	51.92	14.68	15.66	2.54
Net Cash (Debt)	28.41	73.91	82.42	114.63	141.87	90.03
Net Cash Growth	-66.98%	-10.33%	-28.10%	-19.20%	57.58%	509.99%
Net Cash Per Share	0.63	1.69	2.31	3.97	7.69	89.58
Filing Date Shares Outstanding	48.54	44.83	42.74	35.28	27.65	1.75
Total Common Shares Outstanding	47.27	44.83	39.11	31.52	27.61	1.75
Working Capital	50.57	97.89	118.99	116.21	149.19	87.63
Book Value Per Share	0.63	1.64	2.85	3.88	5.53	-29.70
Tangible Book Value	29.61	73.39	111.37	122.34	152.79	-51.86
Tangible Book Value Per Share	0.63	1.64	2.85	3.88	5.53	-29.70
Machinery	-	3.34	3.16	2.32	1.07	0.64
Construction In Progress	-	-	-	0.11	1.96	-
Leasehold Improvements	-	7.97	7.97	7.97	0.27	0.19

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q